Cardiogenic shock: Difference between revisions

Revision as of 21:27, 20 February 2025

File:UOTW 7 - Ultrasound of the Week 1.webm File:UOTW 7 - Ultrasound of the Week 2.webm File:UOTW 7 - Ultrasound of the Week 3.webm Cardiogenic shock is a medical condition characterized by the heart's inability to pump enough blood to meet the body's needs, leading to inadequate tissue perfusion and oxygenation. This condition is a type of circulatory shock and is often a result of severe myocardial infarction (heart attack), but it can also be caused by other cardiac conditions such as cardiomyopathy, valvular heart disease, and severe arrhythmias.

Pathophysiology

Cardiogenic shock occurs when the heart's pumping function is severely impaired. This impairment can be due to:

Myocardial infarction: Damage to the heart muscle reduces its ability to contract.
Cardiomyopathy: Diseases of the heart muscle that affect its ability to pump blood.
Valvular heart disease: Dysfunction of the heart valves can lead to inadequate blood flow.
Arrhythmias: Abnormal heart rhythms can disrupt the heart's ability to pump effectively.

The reduced cardiac output leads to decreased perfusion of vital organs, resulting in symptoms such as hypotension, tachycardia, oliguria, and altered mental status.

Symptoms

The symptoms of cardiogenic shock include:

Severe hypotension
Rapid and weak pulse (tachycardia)
Cold, clammy skin
Oliguria (reduced urine output)
Dyspnea (shortness of breath)
Altered mental status (confusion or loss of consciousness)

Diagnosis

Diagnosis of cardiogenic shock is based on clinical presentation and diagnostic tests, including:

Electrocardiogram (ECG) to detect myocardial infarction or arrhythmias.
Echocardiography to assess heart function and structure.
Blood tests to measure cardiac biomarkers such as troponin.
Hemodynamic monitoring to measure blood pressure and cardiac output.

Treatment

The treatment of cardiogenic shock aims to improve cardiac output and tissue perfusion. It includes:

Pharmacological therapy: Medications such as inotropes and vasopressors to support heart function and blood pressure.
Mechanical support: Devices like intra-aortic balloon pump (IABP) or ventricular assist device (VAD) to support the heart's pumping ability.
Revascularization: Procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) to restore blood flow in cases of myocardial infarction.
Fluid management: Careful administration of fluids to optimize preload without causing fluid overload.

Prognosis

The prognosis of cardiogenic shock depends on the underlying cause and the timeliness of treatment. Despite advances in medical care, cardiogenic shock remains a serious condition with a high mortality rate.

Related Pages

A

B

Brown atrophy of the heart

C

D

E

H

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

K

Keshan disease

L

Loeffler endocarditis

M

N

Nonbacterial thrombotic endocarditis

O

P

R

S